LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer

eLife

Volumn 7, Issue , 2018, Pages

  Lo, Pang Kuo ^a   Yao, Yuan ^a   Lee, Ji Shin ^b   Zhang, Yongshu ^a   Huang, Weiliang ^c   Kane, Maureen A ^c   Zhou, Qun ^a  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b Chonnam National University Medical School   (South Korea)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; SMALL INTERFERING RNA; CYTOKINE; DTX3L PROTEIN, HUMAN; ISG15 PROTEIN, HUMAN; LIPG PROTEIN, HUMAN; TRIACYLGLYCEROL LIPASE; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; DOWN REGULATION; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; ONCOGENE; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; WESTERN BLOTTING; XENOGRAFT; CELL MOTION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

CARCINOGENESIS; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LIPASE; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST NEOPLASMS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS;

EID: 85042118944     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.31334     Document Type: Article

References (65)

1. Bachmann SB, Frommel SC, Camicia R, Winkler HC, Santoro R, Hassa PO. 2014. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells. Molecular Cancer 13:125. DOI: https://doi.org/10.1186/1476-4598-13-125, PMID: 24886089
2. Badellino KO, Wolfe ML, Reilly MP, Rader DJ. 2008. Endothelial lipase is increased in vivo by inflammation in humans. Circulation 117:678-685. DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.707349, PMID: 182122 82
3. Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Rakha EA, Richardson AL, Schmitt FC, Tan PH, Tse GM, Weigelt B, Ellis IO, Reis-Filho JS. 2011. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Modern Pathology 24:157-167. DOI: https://doi.org/10.1038/modpathol.2010.200, PMID: 21076464
4. Baumann J, Sevinsky C, Conklin DS. 2013. Lipid biology of breast cancer. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1831:1509-1517. DOI: https://doi.org/10.1016/j.bbalip.2013.03.011, PMID: 23562840
5. Beloribi-Djefaflia S, Vasseur S, Guillaumond F. 2016. Lipid metabolic reprogramming in cancer cells. Oncogenesis 5:e189. DOI: https://doi.org/10.1038/oncsis.2015.49, PMID: 26807644
6. Broedl UC, Maugeais C, Marchadier D, Glick JM, Rader DJ. 2003. Effects of nonlipolytic ligand function of endothelial lipase on high density lipoprotein metabolism in vivo. Journal of Biological Chemistry 278:40688-40693. DOI: https://doi.org/10.1074/jbc.M304367200, PMID: 12909635
7. Bryan BB, Schnitt SJ, Collins LC. 2006. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Modern Pathology 19:617-621. DOI: https://doi.org/10.1038/modpathol.3800570, PMID: 16528377
8. Burks J, Reed RE, Desai SD. 2014. ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene 33:794-803. DOI: https://doi.org/10.1038/onc.2012.633, PMID: 23318454
9. Cadenas C, Vosbeck S, Hein EM, Hellwig B, Langer A, Hayen H, Franckenstein D, Büttner B, Hammad S, Marchan R, Hermes M, Selinski S, Rahnenführer J, Peksel B, Török Z, Vígh L, Hengstler JG. 2012. Glycerophospholipid profile in oncogene-induced senescence. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1821:1256-1268. DOI: https://doi.org/10.1016/j.bbalip.2011.11.008, PMID: 22178194
10. Chan SR, Vermi W, Luo J, Lucini L, Rickert C, Fowler AM, Lonardi S, Arthur C, Young LJ, Levy DE, Welch MJ, Cardiff RD, Schreiber RD. 2012. STAT1-deficient mice spontaneously develop estrogen receptor a-positive luminal mammary carcinomas. Breast Cancer Research 14:R16. DOI: https://doi.org/10.1186/bcr3100, PMID: 22264274
11. Colmenares SU, Swenson JM, Langley SA, Kennedy C, Costes SV, Karpen GH. 2017. Drosophila histone demethylase kdm4a has enzymatic and non-enzymatic roles in controlling heterochromatin integrity. Developmental Cell 42:156-169. DOI: https://doi.org/10.1016/j.devcel.2017.06.014, PMID: 28743002
12. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Langerød A, Green A, Provenzano E, Wishart G, et al. 2012. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486:346-352. DOI: https://doi.org/10.1038/nature10983, PMID: 22522925
13. Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, Rubin EH, Saleem A, Nur-E-Kamal A, Liu LF. 2006. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Research 66: 921-928. DOI: https://doi.org/10.1158/0008-5472.CAN-05-1123, PMID: 16424026
14. Distler U, Kuharev J, Navarro P, Levin Y, Schild H, Tenzer S. 2014. Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics. Nature Methods 11:167-170. DOI: https://doi.org/10.1038/nmeth.2767, PMID: 24336358
15. Edmondson AC, Brown RJ, Kathiresan S, Cupples LA, Demissie S, Manning AK, Jensen MK, Rimm EB, Wang J, Rodrigues A, Bamba V, Khetarpal SA, Wolfe ML, Derohannessian S, Li M, Reilly MP, Aberle J, Evans D, Hegele RA, Rader DJ. 2009. Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. Journal of Clinical Investigation 119:1042-1050. DOI: https://doi.org/10.1172/JCI37176, PMID: 192 87092
16. Elshamy WM, Duhé RJ. 2013. Overview: cellular plasticity, cancer stem cells and metastasis. Cancer Letters 341: 2-8. DOI: https://doi.org/10.1016/j.canlet.2013.06.020, PMID: 23796691
17. Erde J, Loo RR, Loo JA. 2014. Enhanced FASP (eFASP) to increase proteome coverage and sample recovery for quantitative proteomic experiments. Journal of Proteome Research 13:1885-1895. DOI: https://doi.org/10.1021/pr4010019, PMID: 24552128
18. Forys JT, Kuzmicki CE, Saporita AJ, Winkeler CL, Maggi LB, Weber JD. 2014. ARF and p53 coordinate tumor suppression of an oncogenic IFN-b-STAT1-ISG15 signaling axis. Cell Reports 7:514-526. DOI: https://doi.org/10.1016/j.celrep.2014.03.026, PMID: 24726362
19. Geromanos SJ, Vissers JP, Silva JC, Dorschel CA, Li GZ, Gorenstein MV, Bateman RH, Langridge JI. 2009. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. PROTEOMICS 9:1683-1695. DOI: https://doi.org/10.1002/pmic.200800562, PMID: 19294628
20. Giancotti FG. 2013. Mechanisms governing metastatic dormancy and reactivation. Cell 155:750-764. DOI: https://doi.org/10.1016/j.cell.2013.10.029, PMID: 24209616
21. Glück S, Ross JS, Royce M, McKenna EF, Perou CM, Avisar E, Wu L. 2012. TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab. Breast Cancer Research and Treatment 132:781-791. DOI: https://doi.org/10.1007/s10549-011-1412-7, PMID: 21373875
22. Hadjivasiliou A. 2012. ISG15 implicated in cytoskeleton disruption and promotion of breast cancer. Expert Review of Proteomics 9:7. PMID: 22397023
23. Henry CM, Martin SJ. 2017. Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory “FADDosome” complex upon TRAIL stimulation. Molecular Cell 65:715-729. DOI: https://doi.org/10.1016/j.molcel.2017.01.022, PMID: 28212752
24. Hermann M, Bogunovic D. 2017. ISG15: in sickness and in health. Trends in Immunology 38:79-93. DOI: https://doi.org/10.1016/j.it.2016.11.001, PMID: 27887993
25. Hoeflich KP, O’Brien C, Boyd Z, Cavet G, Guerrero S, Jung K, Januario T, Savage H, Punnoose E, Truong T, Zhou W, Berry L, Murray L, Amler L, Belvin M, Friedman LS, Lackner MR. 2009. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Clinical Cancer Research 15: 4649-4664. DOI: https://doi.org/10.1158/1078-0432.CCR-09-0317, PMID: 19567590
26. Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C. 2008. The CD44+/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Research 10:R53. DOI: https://doi.org/10.1186/bcr2108, PMID: 18559090
27. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K. 2008. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13:394-406. DOI: https://doi.org/10.1016/j.ccr.2008.03.007, PMID: 18455123
28. Jensen MM, Jørgensen JT, Binderup T, Kjaer A. 2008. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. BMC Medical Imaging 8:16. DOI: https://doi.org/10.1186/1471-2342-8-16, PMID: 18925932
29. Juszczynski P, Kutok JL, Li C, Mitra J, Aguiar RC, Shipp MA. 2006. BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate. Molecular and Cellular Biology 26:5348-5359. DOI: https://doi.org/10.1128/MCB.02351-05, PMID: 16809771
30. Kempe S, Kestler H, Lasar A, Wirth T. 2005. NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Research 33:5308-5319. DOI: https://doi.org/10.1093/nar/gki836, PMID: 16177180
31. Koppenol WH, Bounds PL, Dang CV. 2011. Otto Warburg’s contributions to current concepts of cancer metabolism. Nature Reviews Cancer 11:325-337. DOI: https://doi.org/10.1038/nrc3038, PMID: 21508971
32. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. 2011. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. Journal of Clinical Investigation 121:2750-2767. DOI: https://doi.org/10.1172/JCI45014, PMID: 21633166
33. Li GZ, Vissers JP, Silva JC, Golick D, Gorenstein MV, Geromanos SJ. 2009. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 9:1696-1719. DOI: https://doi.org/10.1002/pmic.200800564, PMID: 19294629
34. Lo PK, Zhang Y, Wolfson B, Gernapudi R, Yao Y, Duru N, Zhou Q. 2016. Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis. Oncotarget 7:65067-65089. DOI: https://doi.org/10.18632/oncotarget.11364, PMID: 27556296
35. Lo PK, Zhang Y, Yao Y, Wolfson B, Yu J, Han SY, Duru N, Zhou Q. 2017. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFb signaling. Journal of Biological Chemistry 292:11466-11484. DOI: https://doi.org/10.1074/jbc.M117.775080, PMID: 28512126
36. McCoy MG, Sun GS, Marchadier D, Maugeais C, Glick JM, Rader DJ. 2002. Characterization of the lipolytic activity of endothelial lipase. Journal of Lipid Research 43:921-929. PMID: 12032167
37. Miller FR, Santner SJ, Tait L, Dawson PJ. 2000. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. JNCI: Journal of the National Cancer Institute 92:1185a. DOI: https://doi.org/10.1093/jnci/92.14.1185a
38. Nielsen JE, Lindegaard ML, Friis-Hansen L, Almstrup K, Leffers H, Nielsen LB, Rajpert-De Meyts E. 2010. Lipoprotein lipase and endothelial lipase in human testis and in germ cell neoplasms. International Journal of Andrology 33:e207-e215. DOI: https://doi.org/10.1111/j.1365-2605.2009.00988.x, PMID: 19780863
39. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D. 2000. Molecular portraits of human breast tumours. Nature 406:747-752. DOI: https://doi.org/10.1038/35021093, PMID: 10963602
40. Pinto CA, Widodo E, Waltham M, Thompson EW. 2013. Breast cancer stem cells and epithelial mesenchymal plasticity-Implications for chemoresistance. Cancer Letters 341:56-62. DOI: https://doi.org/10.1016/j.canlet.2013.06.003, PMID: 23830804
41. Qi D, Brownridge P, Xia D, Mackay K, Gonzalez-Galarza FF, Kenyani J, Harman V, Beynon RJ, Jones AR. 2012. A software toolkit and interface for performing stable isotope labeling and top3 quantification using Progenesis LC-MS. OMICS: A Journal of Integrative Biology 16:489-495. DOI: https://doi.org/10.1089/omi.2012.0042, PMID: 22888986
42. Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, El-Sayed ME, Benhasouna A, Brunet JS, Akslen LA, Evans AJ, Blamey R, Reis-Filho JS, Foulkes WD, Ellis IO. 2009. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clinical Cancer Research 15:2302-2310. DOI: https://doi.org/10.1158/1078-0432.CCR-08-2132, PMID: 19318481
43. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM. 2007. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9:166-180. DOI: https://doi.org/10.1593/neo.07112, PMID: 17356713
44. Robert J, Lehner M, Frank S, Perisa D, von Eckardstein A, Rohrer L. 2013. Interleukin 6 stimulates endothelial binding and transport of high-density lipoprotein through induction of endothelial lipase. Arteriosclerosis, Thrombosis, and Vascular Biology 33:2699-2706. DOI: https://doi.org/10.1161/ATVBAHA.113.301363, PMID: 24115033
45. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS 98:10869-10874. DOI: https://doi.org/10.1073/pnas.191367098, PMID: 11553815
46. Santos CR, Schulze A. 2012. Lipid metabolism in cancer. FEBS Journal 279:2610-2623. DOI: https://doi.org/10.1111/j.1742-4658.2012.08644.x, PMID: 22621751
47. Sgorbissa A, Brancolini C. 2012. IFNs, ISGylation and cancer: Cui prodest? Cytokine & Growth Factor Reviews 23:307-314. DOI: https://doi.org/10.1016/j.cytogfr.2012.07.003, PMID: 22906767
48. Slebe F, Rojo F, Vinaixa M, García-Rocha M, Testoni G, Guiu M, Planet E, Samino S, Arenas EJ, Beltran A, Rovira A, Lluch A, Salvatella X, Yanes O, Albanell J, Guinovart JJ, Gomis RR. 2016. FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth. Nature Communications 7:11199. DOI: https://doi.org/10.1038/ncomms11199, PMID: 27045898
49. Snell LM, McGaha TL, Brooks DG. 2017. Type I interferon in chronic virus infection and cancer. Trends in Immunology 38:542-557. DOI: https://doi.org/10.1016/j.it.2017.05.005, PMID: 28579323
50. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. PNAS 100:8418-8423. DOI: https://doi.org/10.1073/pnas.0932692100, PMID: 12829800
51. Sosa MS, Bragado P, Aguirre-Ghiso JA. 2014. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nature Reviews Cancer 14:611-622. DOI: https://doi.org/10.1038/nrc3793, PMID: 25118602
52. Strauss JG, Zimmermann R, Hrzenjak A, Zhou Y, Kratky D, Levak-Frank S, Kostner GM, Zechner R, Frank S. 2002. Endothelial cell-derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL-associated cholesterol esters independent of its enzymic activity. Biochemical Journal 368:69-79. DOI: https://doi.org/10.1042/bj20020306, PMID: 12164779
53. Thang ND, Yajima I, Kumasaka MY, Iida M, Suzuki T, Kato M. 2015. Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway. Oncotarget 6:14290-14299. DOI: https://doi.org/10.18632/oncotarget.3742, PMID: 26033450
54. Thike AA, Iqbal J, Cheok PY, Tse GM, Tan PH. 2013. Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor-product relationship. Journal of Clinical Pathology 66:665-670. DOI: https://doi.org/10.1136/jclinpath-2012-201428, PMID: 23539741
55. Trackman PC. 2016. Enzymatic and non-enzymatic functions of the lysyl oxidase family in bone. Matrix Biology. 52:7-18. DOI: https://doi.org/10.1016/j.matbio.2016.01.001, PMID: 26772152
56. Tsuji T, Ibaragi S, Shima K, Hu MG, Katsurano M, Sasaki A, Hu GF. 2008. Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Research 68:10377-10386. DOI: https://doi.org/10.1158/0008-5472.CAN-08-1444, PMID: 1 9074907
57. Wang X, Jin W, Rader DJ. 2007. Upregulation of macrophage endothelial lipase by toll-like receptors 4 and 3 modulates macrophage interleukin-10 and-12 production. Circulation Research 100:1008-1015. DOI: https://doi.org/10.1161/01.RES.0000263011.34709.c5, PMID: 17347473
58. Wiśniewski JR, Zougman A, Nagaraj N, Mann M. 2009. Universal sample preparation method for proteome analysis. Nature Methods 6:359-362. DOI: https://doi.org/10.1038/nmeth.1322, PMID: 19377485
59. Yan Q, Dutt S, Xu R, Graves K, Juszczynski P, Manis JP, Shipp MA. 2009. BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response. Molecular Cell 36:110-120. DOI: https://doi.org/10.1016/j.molcel.2009.08.019, PMID: 19818714
60. Yan Q, Xu R, Zhu L, Cheng X, Wang Z, Manis J, Shipp MA. 2013. BAL1 and its partner E3 ligase, BBAP, link Poly (ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8. Molecular and Cellular Biology 33:845-857. DOI: https://doi.org/10.1128/MCB.00990-12, PMID: 23230272
61. Yasuda T, Hirata K, Ishida T, Kojima Y, Tanaka H, Okada T, Quertermous T, Yokoyama M. 2007. Endothelial lipase is increased by inflammation and promotes LDL uptake in macrophages. Journal of Atherosclerosis and Thrombosis 14:192-201. DOI: https://doi.org/10.5551/jat.E502, PMID: 17726294
62. Zhang X, Bogunovic D, Payelle-Brogard B, Francois-Newton V, Speer SD, Yuan C, Volpi S, Li Z, Sanal O, Mansouri D, Tezcan I, Rice GI, Chen C, Mansouri N, Mahdaviani SA, Itan Y, Boisson B, Okada S, Zeng L, Wang X, et al. 2015a. Human intracellular ISG15 prevents interferon-a/b over-amplification and auto-inflammation. Nature 517:89-93. DOI: https://doi.org/10.1038/nature13801, PMID: 25307056
63. Zhang Y, Mao D, Roswit WT, Jin X, Patel AC, Patel DA, Agapov E, Wang Z, Tidwell RM, Atkinson JJ, Huang G, McCarthy R, Yu J, Yun NE, Paessler S, Lawson TG, Omattage NS, Brett TJ, Holtzman MJ. 2015b. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nature Immunology 16:1215-1227. DOI: https://doi.org/10.1038/ni.3279, PMID: 26479788
64. Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM. 2004. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. PNAS 101:7578-7582. DOI: https://doi.org/10.1073/pnas.0402528101, PMID: 15131269
65. Zhu Y, Yang R, McLenithan J, Yu D, Wang H, Wang Y, Singh D, Olson J, Sztalryd C, Zhu D, Gong DW. 2015. Direct conversion of human myoblasts into brown-like adipocytes by engineered super-active PPARg. Obesity 23:1014-1021. DOI: https://doi.org/10.1002/oby.21062, PMID: 25919922